US20090226957A1 - Process and device for separating biological particles contained in a fluid by means of filtration - Google Patents
Process and device for separating biological particles contained in a fluid by means of filtration Download PDFInfo
- Publication number
- US20090226957A1 US20090226957A1 US11/908,545 US90854506A US2009226957A1 US 20090226957 A1 US20090226957 A1 US 20090226957A1 US 90854506 A US90854506 A US 90854506A US 2009226957 A1 US2009226957 A1 US 2009226957A1
- Authority
- US
- United States
- Prior art keywords
- filter
- filtration
- fluid
- filtration module
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001914 filtration Methods 0.000 title claims abstract description 170
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000002245 particle Substances 0.000 title claims abstract description 36
- 239000012530 fluid Substances 0.000 title claims description 69
- 238000004458 analytical method Methods 0.000 claims abstract description 29
- 238000000746 purification Methods 0.000 claims abstract description 4
- 230000000717 retained effect Effects 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 62
- 239000011148 porous material Substances 0.000 claims description 18
- 239000013060 biological fluid Substances 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 210000002700 urine Anatomy 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000003745 diagnosis Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000009123 Fibrin Human genes 0.000 claims description 4
- 108010073385 Fibrin Proteins 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 206010003445 Ascites Diseases 0.000 claims description 3
- 206010015866 Extravasation Diseases 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 238000001574 biopsy Methods 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 230000036251 extravasation Effects 0.000 claims description 3
- 230000003328 fibroblastic effect Effects 0.000 claims description 3
- 210000004524 haematopoietic cell Anatomy 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 210000004291 uterus Anatomy 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 210000001772 blood platelet Anatomy 0.000 claims description 2
- 239000006285 cell suspension Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 230000003511 endothelial effect Effects 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 210000005036 nerve Anatomy 0.000 claims description 2
- 235000019833 protease Nutrition 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 239000002699 waste material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract 3
- 239000000523 sample Substances 0.000 description 14
- 239000012472 biological sample Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000001001 laser micro-dissection Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
- B01L3/50255—Multi-well filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
- B01L9/523—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips for multisample carriers, e.g. used for microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0631—Purification arrangements, e.g. solid phase extraction [SPE]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
- B01L2400/049—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics vacuum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
Definitions
- the present invention relates to the separation of biological particles contained in a fluid, which can be separated on the basis of their size, separation being carried out by vertical filtration using a filter suited to the nature of the particles to be isolated.
- the particles are isolated in particular for the purposes of purification or analysis and possibly for diagnosis.
- the device used to contain the sample of fluid to be filtered comprises a mechanism to achieve a seal that is rather inconvenient to use.
- the object of the invention is to overcome this drawback by offering a means of making the operation of isolating by vertical filtration the cells contained in a fluid or more generally of separating biological particles from a fluid that contains them more reliable so as to make it suitable in particular for use for diagnostic purposes.
- the invention relates to a process for separating biological particles and the fluid that contains them for the purposes of purification or analysis and possibly for diagnosis, comprising at least one vertical filtration stage through a filter the porosity of which is suited to the nature of the biological particles to be separated so that said biological particles are retained by the filter, characterised in that a filter is used comprising at least one elementary filtration area, each elementary filtration area having a limited surface, and in that the surface of each elementary filtration area and the number of elementary filtration areas is chosen according to the nature of the fluid to be filtered, the nature of the biological particles to be separated and the volume of fluid to be filtered.
- Each elementary filtration area of said process has a surface equal to that of a disk with a diameter of between 0.6 cm and 3 cm, and the number of elementary filtration area is chosen so that the ratio of the volume of fluid filtered to the filtration surface is less than 40 ml/cm 2 , and preferably greater than 0.14 ml/cm 2 .
- each elementary filtration area has a surface equal to that of a disk with a diameter greater than or equal to 0.8 cm.
- the filter has pores calibrated to a size of between 3 ⁇ m and 100 ⁇ m and a pore density of between 3 ⁇ 10 3 and 5 ⁇ 10 6 pores/cm 2 .
- filtration is carried out by a reduction in pressure of between 0.05 bar and 1 bar with, possibly, an increase in pressure of less than 1 bar.
- a filter forming a badge suitable to be associated with a means of analysing filtration residues by locating the elementary filtration areas.
- the badge forming the filter is incorporated in a single-use filtration module comprising at least one chamber for containing the fluid to be filtered, and that can be treated before use to sterilise it or to free it from enzymes that digest DNA, RNA or proteins.
- the biological particles to be separated are, for example, cells.
- a sample of fluid for filtering may be prepared from a sample of fluid containing cells such as a biological fluid or cell culture by pre-enriching it with the cells to be separated and/or by diluting it.
- the fluid containing the cells may be blood and, preferably, the filter in this case has calibrated pores of between 5 ⁇ m and 25 ⁇ m.
- the biological particles may also be fibrins.
- the fluid containing the biological particles is urine and the calibrated pores of the filter are between 8 ⁇ m and 100 ⁇ m.
- the process can be used for the detection of cells for diagnostic purposes such as tumour, foetal, endothelial, fibroblastic, muscle, nerve or monocytal cells, cell strains, organ cells, precursors or haematopoietic cells, in a biological fluid such as blood, urine, ascites, cephalorachidian fluid, milk, pleural extravasation, fluid for washing the neck of the uterus, cell suspension fluid obtained by biopsy, by a surgical method or by mouth washing, or for the detection of animal or vegetable cells.
- a biological fluid such as blood, urine, ascites, cephalorachidian fluid, milk, pleural extravasation, fluid for washing the neck of the uterus, cell suspension fluid obtained by biopsy, by a surgical method or by mouth washing, or for the detection of animal or vegetable cells.
- the invention also relates to a filtration module for implementing the process, said module comprising:
- each opening in the base of the chamber block and the dimensions of each hole in the filter support drawer are such that each pair made up of an opening in the base of the chamber block and the associated hole in the filter support draw, define an elementary filtration area of limited surface and in that the useful volume of each compartment is proportional to the number of elementary filtration areas situated in the base of the compartment.
- the surface of an elementary filtration area is equal to that of a disk with an equivalent diameter of between 0.6 cm and 3 cm, and the ratio of the useful volume of each compartment to the sum of the surfaces of the openings comprised in the base of the compartment is less than 40 ml/cm 2 , and preferably greater than 0.14 ml/cm 2 .
- the dimensions of at least one opening in the base of the chamber block and of a corresponding hole in the filter support drawer are such that the surface of the corresponding elementary filtration area is greater than or equal to that of a disk 0.8 cm in diameter.
- At least one compartment may be divided into part compartments by at least one removable separation wall, such that at least one part compartment comprises in its base at least one opening and that the ratio of the volume of said part compartment to the sum of the surfaces of the openings in the base of the part compartment is less than 40 ml/cm 2 , and preferably greater than 0.14 ml/cm 2 .
- the filtration module comprises a grooved sealing joint arranged between the base of the chamber block and the filter, comprising at least one hole corresponding to a hole in the base of the chamber block, the hole being surrounded by at least one projecting lip.
- the filtration module preferably also comprises a plate joint between the filter and the filter support, comprising at least one opening opposite a hole in the filter support.
- the filter may form a badge the central portion of which comprises at least one porous area and the periphery of which forms a frame comprising means for indexing its position on the filter support.
- the indexation means are, for example, at least two holes of different diameter designed to cooperate with studs of corresponding diameter provided on the filter support.
- At least a central porous portion of the filter comprises between 3 ⁇ 10 3 and 5 ⁇ 10 6 pores per cm 2 of between 3 ⁇ m and 100 ⁇ m.
- the filtration module also comprises at least one stopper for closing the upper opening of a compartment.
- the chamber block comprises, at its lower portion, a rim extending outwards and cooperating with at least one assembly pin allowing the filter to be gripped between the filter support and the chamber block, the assembly pin comprising a breakable end extending above the rim of the chamber block.
- all its parts are made of materials suited to a sterilisation operation or designed to render them free from RNases, DNases or proteinases.
- the invention relates to a filtration module support for retaining a filtration module on a filtration machine, comprising at least one cam that can move between an open position and a gripping position, designed to put pressure on the filter between the filter support and the chamber block.
- At least one cam is designed so that, if the filtration module comprises at least one fixing pin one end of which is breakable, the end of at least one fixing pin is cut when pressure is applied to the filter by at least one cam.
- the support block forms part of a filtration machine.
- the filtration module also comprises a means designed to cooperate with a complementary means on a support block, so as to impose the orientation of the filtration module in relation to the support block
- the support block comprises a means designed to cooperate with a means on a filtration module, so as to index the orientation of the filtration module in relation to the support block.
- FIG. 1 is a perspective view of a filtration module associated with a filtration module support block
- FIG. 2 is an exploded perspective view of a filtration module
- FIGS. 3A and 3B are two views in cross-section of a chamber block of a filtration module
- FIG. 4 is a perspective view with cross-section of a grooved sealing joint
- FIGS. 5A and 5B are perspective views, in particular with a cross section, of a filter support drawer
- FIG. 6A is a perspective view of a filtration module arranged on a support block
- FIG. 6B is an enlarged perspective view of means for gripping the base of a filtration module arranged on a support block of the filtration module;
- FIG. 7 is a separated perspective view of a filtration module after use, in which the chamber block is separated from the filter support drawer comprising a filter.
- FIG. 8 is a perspective view of a filtration module according to a variant.
- FIG. 9 is a perspective view of a badge-filter.
- the method for isolating biological particles contained in a fluid consists of filtering the fluid on a filter with characteristics suited to the nature of the particles to be isolated.
- the biological particles may be cells, red blood cells, platelet aggregates, fibrins or tissue waste.
- the filtered fluid is in particular a fluid obtained from a sample of biological fluid that may have undergone prior treatment to facilitate the isolation by filtering operation.
- This prior operation comprises in general, particularly when the particles to be isolated are cells, one or a plurality of the following operations: chemical treatment designed to pre-enrich the cell to be isolated, dilution, chemical treatment designed to facilitate separation by filtration of the cells to be isolated.
- the filter must be divided into elementary filtration area each having a surface equal to that of a disk of diameter of between 0.6 cm and 3 cm, and preferably greater than 0.8 cm and even better between 0.8 cm and 1.5 cm.
- the elementary filtration areas may be in the shape of a disk, for example.
- the quantity of fluid to be filtered which must pass through each of the elementary filtration areas, must be between 1 ml and 100 ml, and preferably this volume should be between 8 ml and 15 ml.
- a device To filter a particular sample a device must be used to define a number of elementary filtration areas on the filter in proportion to the volume of the sample to be filtered.
- the volume of the sample to be filtered depends on the one hand on the volume of biological fluid that could be taken initially, and on the other hand on a possible dilution which depends in particular on the nature of the biological particles to be separated.
- the volume taken depends in particular on the nature of the fluid taken and the age of the patient from whom the fluid is taken. A person skilled in the art knows how to determine the volumes to be taken depending on the nature of the fluid taken and on the patient from whom it is taken.
- Dilution depends in particular on the number of particles per unit of volume that can be found in the fluid taken. Indeed, if filtration is to be carried out under satisfactory conditions, the number of particles to be isolated per unit of volume of fluid to be filtered should not be too great to avoid clogging the filter. Moreover, if the process is intended to detect particular rare cells mixed with a far greater number of cells, the number of cells per unit of volume should not be too small, so as to achieve a reasonable probability of finding the cells sought on the filter. A person skilled in the art also knows how to determine these dilution rates depending on the nature of the fluid in question and the type of cell sought.
- the biological sample taken from a patient may, for example, be blood, urine, ascites, cephalorachidian fluid, milk or pleural extravasation; it may also be fluid from washing the neck of the uterus or any other fluid that may result from taking a biological sample from a patient.
- the analysis method may also be used to search for cells in samples that have not been taken directly from patients, and for example, in samples taken in cell culture mediums made from smears or biopsies or from human or animal tissue samples or, further, in human or animal cell line culture mediums.
- the amount taken is generally between 1 ml and 20 ml, and the blood is diluted by a ratio that varies from 1 in 5 to 1 in 20 to obtain a sample of fluid for filtering which, in these conditions, is filtered over one to 20 elementary filtration areas.
- the samples are approximately 5 ml to 10 ml and are diluted in a ratio of between 1 in 2 and 1 in 10, or they may not be diluted. These samples are filtered over a number of elementary filtration areas which may be as many as 5 or even more, particularly if it is a 10 ml sample that has been diluted in a ratio of 1 in 10.
- the cells that may be sought are in particular tumour cells, foetal cells, endothelial cells, fibroblastic cells, muscle cells, nerve cells, monocytal cells, cell strains, organ cells (hepatic, renal, etc. . . . ), precursors and haematopoietic cells.
- tumour cells foetal cells, endothelial cells, fibroblastic cells, muscle cells, nerve cells, monocytal cells, cell strains, organ cells (hepatic, renal, etc. . . . ), precursors and haematopoietic cells.
- This list which is given as an example, is not limitative.
- the cells Before filtration, the cells may be pre-enriched by treatment of the density gradient type or by lysis of cells that are of no interest, or by immunomediated methods, by positive or negative screening, by stimulating the cells sought to proliferate, etc.
- the fluid sample containing cells may be treated by a reagent according to the nature of the cells sought, to facilitate the separation by filtration operation.
- the aim of the treatment may be to lyse red blood cells and anticoagulate the blood if the biological sample contains blood, and consists, for example, of adding saponin and EDTA.
- the aim of the treatment may also be to fix nucleated cells, for example by the addition of formaldehyde, if the filtration is intended to isolate fixed cells.
- the object of the treatment is to make enrichment possible.
- the biological sample may be treated with a reagent and under conditions suitable for temporarily rendering biological membranes rigid (for example, by the addition of polysaccharide, DMSO, by cold, etc.).
- the biological sample which may have been diluted, pre-enriched or treated with a reagent to allow filtration suited to the end sought, is then filtered through a filter made of polycarbonate or an equivalent material that has calibrated pores of a size between 1 ⁇ m and 100 ⁇ m and suited to the nature of the particles to be separated.
- This size is preferably between 3 ⁇ m and 25 ⁇ m, and is about 8 ⁇ m, for example, particularly if tumour cells or epithelial cells are to be isolated.
- Pore density is suited to the nature of the particles to be separated.
- the pore density of the filter is between 5 ⁇ 10 3 and 5 ⁇ 10 6 pores/cm 2 and even better between 5 ⁇ 10 4 and 5 ⁇ 10 5 pores/cm 2 .
- Filtration is performed preferably be a reduction in pressure of between 0.05 bar and 1 bar, and preferably of approximately 0.1 bar. Filtration may be assisted by a slight increase in pressure on the fluid situated above the filter. This increase in pressure must however be less than 1 bar. These conditions are particularly suited to cell separation.
- the process may be used for different objectives, for example to search for rare cells in suspension in a biological fluid, so as to allow diagnosis or to purify a fluid to allow analysis in good conditions of the elements in solution.
- the filter that has been used to filter the fluid is recovered ensuring that the filtration areas are clearly identified and that a link can be made between these filtration areas and the sample that was filtered.
- the filter is then used to analyse the cells that it may have been possible to recover in the filtration areas.
- cytological staining haematoxylin, eosin, etc.
- immunomarking immunohistochemistry, immunofluorescence
- FISH FISH
- PRINS PCR in situ or other molecular technique
- spectrophotometry laser microdissection followed by targeted molecular analyses on the DNA
- RNA extraction and analysis by PCR of transcripts, quantitative PCR
- proteins protein extraction, microsequencing, etc.
- the molecular analyses may be performed on enriched cells held on the filter and transposed onto a slide by a technique similar to the Southern technique, individually micro-dissected from the filter or from the slide according to defined criteria (morphological characteristics of the cells with or without marking of different natures) and subjected to individual or pooled molecular analysis.
- the cells may also be detached from the filter by washing with an appropriate buffer to extract and analyse their DNA, RNA and proteins.
- the elements isolated by filtration are then examined with a microscope and analysis of the images obtained on the filter may be carried out manually or by automated means, in particular by using image analysis equipment.
- the process may also be used to purify a biological fluid such as urine containing in solution the DNA, RNA or proteins that are to be analysed.
- a biological fluid such as urine containing in solution the DNA, RNA or proteins that are to be analysed.
- the purpose of purifying the fluid is to eliminate all the biological particles present in the fluid, which could interfere with the analysis. In this case, the filters are not kept and it is the filtered fluid that is analysed.
- This filtration method and the sample preparation and analysis methods may be used as stated previously in particular for the purpose of diagnosis to detect pathologies associated with the presence of particular cells possibly in extremely small quantities.
- the process can be used to detect cancerous cells that may have been released into a patient's blood during a surgical operation.
- a person skilled in the art knows what cells can be searched for to detect a particular pathology.
- appliances used should provide good reproducibility and reliability of the conditions in which the analysis was performed. Accordingly, the inventors have developed devices suitable for performing these analyses in conditions of satisfactory reliability.
- the fluids to be filtered are collected in a filtration module, preferably a single-use filtration module, referenced generally as 1 in FIG. 1 and designed to be mounted on a support block referenced generally as 2 , forming part of the filtration machine (which is not illustrated in its entirety in the figure).
- a filtration module preferably a single-use filtration module, referenced generally as 1 in FIG. 1 and designed to be mounted on a support block referenced generally as 2 , forming part of the filtration machine (which is not illustrated in its entirety in the figure).
- the filtration module 1 is placed on the support block to perform the filtration. When filtration has finished, the filtration module 1 is removed from the support block 2 and the filter contained in the filtration module is removed so that the analyses can be performed as will be explained later.
- the filtration module 1 illustrated in exploded form in FIG. 2 , consists of a stack comprising, from top to bottom, a chamber block 11 , a grooved joint 12 , a filter 13 , a plate joint 14 and a filter support drawer 15 .
- the filter 13 is laid flat against the lower face 110 of the chamber block 11 by means of the filter support drawer 15 , the seal between the filter 13 and the chamber block 11 being provided by the grooved joint 12 , and the seal between the filter 13 and the filter support drawer 15 being provided by the plate joint 14 .
- the filter support drawer When the assembly is fitted together, the filter support drawer is held in position against the chamber block 11 by means of two assembly pins 16 which pass through holes 151 in the filter support drawer and hook into holes 112 provided in a lower rim 111 of the chamber block 11 , extending outwards.
- the chamber block 11 made of plastics material, comprises a body 114 divided into two compartments 113 open at their upper portion 115 and closed at their lower portion by a base 116 comprising a plurality of circular openings 117 with a diameter of between 0.6 cm and 2 cm.
- the base also comprises a rim 111 forming a small collar in which openings 112 designed to receive the hooks of the assembly pins 16 are provided on the two side portions of the chamber block.
- the compartments 113 may be closed at their upper portion by removable stoppers 17 .
- the fillet radii of the base and walls of each compartment are rounded so as not to create an area where particles to be filtered can be trapped.
- the compartments 113 may comprise vertical grooves 118 designed to receive separation slides 119 allowing the compartments 113 to be divided into part compartments of smaller volume.
- the grooves 118 are arranged such that any separation slides 119 are always arranged between two circular openings 117 .
- the volume of the compartments is in proportion to the number of circular openings 117 , such that the total volume of the compartment or more precisely the maximum quantity of fluid that the compartment can receive is between 0.14 ml/cm 2 and 40 ml/cm 2 multiplied by the sum of the surfaces of the openings comprised in the base of the compartment.
- the height of the compartment and the cross-section of the base are such that not only are these conditions respected for a complete compartment but also such that they are respected for any part compartment delimited by means of one or a plurality of removable sealed separation walls 119 .
- each compartment may have a volume of 110 ml and comprise 5 openings in the base.
- the chamber block 11 comprises a compartment 113 , comprising five elementary filtration areas, a compartment 113 A comprising one elementary filtration area and two compartments 113 B comprising two elementary filtration areas.
- Each compartment comprises a removable stopper 17 , 17 A, 17 B. It will be noted that with this arrangement, it is possible to choose the number of elementary filtration area used from between 1 and 10.
- the chamber block On its lower face 110 , the chamber block comprises two holes of different diameter (not visible on the figure) arranged diagonally, designed to cooperate with studs 153 A and 153 B of the filter support drawer 15 , to ensure precise positioning and location of the position of the filter in relation to the base of the chamber block.
- the grooved joint 12 arranged just beneath the chamber block is made of moulded silicon and comprises a plurality of holes 121 designed to face the openings 117 provided in the base of the chamber block, these holes 121 being surrounded by circular lips 122 , and preferably by two circular lips, to provide a good seal.
- the joint may also comprise longitudinal grooves 123 for separating a first series of holes from a second series of holes, to provide separation between the holes opposite a first compartment and the holes opposite the second compartment of the chamber block.
- the function of this joint is to provide a perfect seal between each of the holes so that the fluid passing through a hole cannot be mixed with the fluid passing through another hole, which allows simultaneous filtration of two different fluids.
- the projecting lips 122 , and possibly 123 are arranged on the face 124 of the joint designed to cooperate with the lower portion of the chamber block 11 .
- the second face 125 of the joint, designed to cooperate with the filter 13 is flat.
- the filter 13 which forms a badge of generally rectangular shape and which is flat, comprises a central filtration area 131 consisting of a membrane made of microporous polycarbonate, about 100 ⁇ m thick and of a porosity appropriate to the process. This central portion is fixed using biological glue on a PVC frame 132 that can be used to grasp the badge and on which reference inscriptions can be made.
- the frame 132 comprises means for positioning and locating the orientation of the badge consisting of two holes 133 A and 133 B arranged diagonally on the badge and having different diameters designed to cooperate with the studs 153 A and 153 B of the filter support.
- location holes 133 A and 133 B only one orientation is possible to arrange the badge on a support comprising complementary location studs for the holes 133 A and 133 B. This allows the orientation of the badge to be located very exactly on the one hand when it is arranged in the separation module and on the other hand when it is arranged on an analysis appliance such as equipment for staining or reading under a microscope.
- the badge comprises two central filtration areas 131 A, 131 B parallel to each other and which may comprise membranes of different porosity.
- the plate joint 14 is a flat plate joint made of silicon comprising circular openings 140 corresponding to openings 121 in the grooved joint and to openings 117 provided in the base of the chamber block. It also comprises holes 141 A and 141 B of different diameter corresponding to the holes 133 A and 133 B of the filter.
- the filter support drawer 15 is a plate made of injected plastics material comprising an upper face 150 designed to grip the filter and joints assembly against the lower face 110 of the chamber block 11 .
- This filter support plate comprises a series of holes 152 designed to face the corresponding holes 140 of the plate joint, 121 of the grooved joint and 117 of the chamber block.
- the upper face 150 of the filter support drawer also comprises studs 153 A and 153 B designed to cooperate with the location holes 133 A and 133 B of the filter badge 13 , with the corresponding holes 141 A and 141 B of the plate joint 14 and with the centering holes provided on the lower face 110 of the chamber block.
- the holes 152 designed to allow the filtered fluid to pass through comprise an upper portion in the form of a funnel which is extended by small tubes 154 projecting on the lower face 155 of the filter support drawer 15 .
- the function of the small tubes 154 projecting in relation to the lower face 155 of the filter support drawer is to ensure that the fluid flows properly after filtration so that no drops are formed that could moisten the lower face of the filter support.
- the diameter of the upper portion of the holes 152 like the diameter of the holes 140 of the plate joint and 151 of the grooved joint, are substantially equal to the diameter of the holes 117 provided in the base of the chamber block, in order to delimit elementary filtration areas of corresponding diameter on the filter.
- the filter support drawer 15 also comprises holes 151 on its two side edges designed to receive the assembly pins 16 . These holes are of a suitable shape to allow the introduction of the assembly pins and lock the unit in position when assembling the filtration module unit.
- the assembly pins 16 each comprise a head 161 surmounted by a stem 162 , of smaller diameter, the end of which forms a hook 163 .
- the length of the assembly pin is suitable to allow the stack made up of the filter support drawer, the joints and the filter to be locked when it is laid flat against the chamber block.
- an assembly pin is of sufficient length to ensure that, when it is introduced into a hole 151 of the filter support drawer, it can penetrate into the hole 112 of the lower rim of the chamber block 11 , such that the hook 163 situated at the end of the assembly pin can hook on the upper surface of the rim 111 of the chamber block, the head 161 of the assembly pin 16 cooperating with the lower face of the filter support drawer 15 so as to maintain the filter support drawer locked against the base of the chamber block 11 .
- the filtration module as just described is designed to be arranged on a support block 2 of the filtration module, which comprises on the one hand a support face 200 comprising a central opening 201 designed to face all the openings on the lower face of a filtration block, on the other hand a lever 202 pivoting about a pin 203 designed to manoeuvre two cams 204 (only one of which can be seen in the figure) for gripping the lower portion of the filtration module tightly against the surface 200 of the support block, and thereby to grip the chamber block 11 tightly against the filter support drawer 15 during filtration operations.
- the lower rim 111 of the chamber block and, possibly the filter support drawer 15 comprise at one end, an enlarged portion 114 designed to cooperate with an enlarged portion 203 of the runner 204 of the support block 2 designed to receive the base of the filtration module.
- This arrangement allows an orientation to be imposed on the filtration module in relation to the support block.
- the cams are facing the rim 111 of the chamber block 11 , such that when the lever is in the open position, the cams leave room for the rim 111 to slide on the upper face 200 of the support block, and when the lever is in the gripping position, the cams rest firmly on the rim 111 of the chamber block 11 , so as to grip the unit formed by the filtration block, the filter, the filter support and the associated joints, against the face 200 of the filtration module support.
- each cam comprises a vane 205 projecting outwards which, when the rim of the filtration module is tightened, cooperates with the end of the corresponding assembly pin 16 , in order to break the hook so that, when full tightening has been achieved, the hook of the assembly pin is broken.
- a block that does not comprise breakable hooks can also be used. Such a block can then be used repeatedly, which is less reliable than a single use, but may nevertheless have attractions in some cases.
- the filtration module is closed using the upper stoppers and sterilised. If a sample is to be filtered for analysis purposes, a sterilised filtration module is taken and arranged on a support block of a filtration machine. Using the tightening lever, the filtration module is locked on the filtration machine ensuring that the filter support plate is gripped firmly against the base of the chamber block. By doing this, if it is a single-use module, the ends of the assembly pins comprising hooks are broken.
- At least one of the compartments into which the fluid to be filtered is introduced is then opened so that, in each compartment, the ratio of the amount of fluid contained to the sum of the surfaces of the openings of the base of the compartment is between 0.14 and 40 ml/cm 2 . Filtration is then carried out. Once the filtration is performed, the system is unlocked by raising the tightening lever, and the filtration module is removed.
- the lower portion made up of the filter support plate is not integral with the chamber block.
- the unit is therefore separated and the filter is then removed and arranged on the platen of an observation microscope, possibly after having made a number of preparations using reagents to allow convenient observation of the cells that may have been trapped by the filter.
- This single-use device has the advantage of providing good analysis security. In fact, the same device is used only to analyse a single sample, which avoids all risk of a sample being contaminated by earlier samples that may have been analysed using the same device. Moreover, because of the particular geometric characteristics of both the holes arranged in the base of the chamber and of the chamber sizes, the amounts of fluid filtered by the device are suitable to ensure that the amounts filtered on each of the elementary filtration areas of the filter comply with the conditions imposed by the process to achieve reliable results.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502945 | 2005-03-24 | ||
| FR0502945A FR2883488B1 (fr) | 2005-03-24 | 2005-03-24 | Procede et dispositif pour separer par filtration verticale des particules biologiques contenues dans un liquide |
| PCT/FR2006/000562 WO2006100366A2 (fr) | 2005-03-24 | 2006-03-14 | Procede et dispositif pour separer par filtration verticale des particules biologiques contenues dans un liquide |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2006/000562 A-371-Of-International WO2006100366A2 (fr) | 2005-03-24 | 2006-03-14 | Procede et dispositif pour separer par filtration verticale des particules biologiques contenues dans un liquide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/517,288 Continuation US9766167B2 (en) | 2005-03-24 | 2014-10-17 | Process and device for separating biological particles contained in a fluid by means of filtration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20090226957A1 true US20090226957A1 (en) | 2009-09-10 |
Family
ID=35229619
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/908,545 Abandoned US20090226957A1 (en) | 2005-03-24 | 2006-03-14 | Process and device for separating biological particles contained in a fluid by means of filtration |
| US14/517,288 Expired - Lifetime US9766167B2 (en) | 2005-03-24 | 2014-10-17 | Process and device for separating biological particles contained in a fluid by means of filtration |
| US15/707,993 Expired - Lifetime US10436686B2 (en) | 2005-03-24 | 2017-09-18 | Process and device for separating biological particles contained in a fluid by means of filtration |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/517,288 Expired - Lifetime US9766167B2 (en) | 2005-03-24 | 2014-10-17 | Process and device for separating biological particles contained in a fluid by means of filtration |
| US15/707,993 Expired - Lifetime US10436686B2 (en) | 2005-03-24 | 2017-09-18 | Process and device for separating biological particles contained in a fluid by means of filtration |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20090226957A1 (https=) |
| EP (2) | EP1866091B1 (https=) |
| JP (1) | JP5254000B2 (https=) |
| CA (1) | CA2601451C (https=) |
| DK (1) | DK2633912T3 (https=) |
| ES (1) | ES2549856T3 (https=) |
| FR (2) | FR2883488B1 (https=) |
| HU (1) | HUE032161T2 (https=) |
| WO (1) | WO2006100366A2 (https=) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104670A1 (en) * | 2007-09-21 | 2011-05-05 | Metagenex | Method, device and molecular biology kit for extracting amplified genetic material |
| US20130074613A1 (en) * | 2010-04-15 | 2013-03-28 | Cytogen Co., Ltd. | Microfluidic device and method for isolating target using same |
| CN103255055A (zh) * | 2013-04-24 | 2013-08-21 | 宁波美晶医疗技术有限公司 | 一种卡扣型生物芯片 |
| WO2013174948A1 (en) | 2012-05-24 | 2013-11-28 | Rarecells | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| US8709786B2 (en) | 2009-11-04 | 2014-04-29 | Screencell | Device and process for isolating and cultivating live cells on a filter or extracting their genetic material |
| US20140323911A1 (en) * | 2013-03-15 | 2014-10-30 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
| US9908113B2 (en) | 2013-03-15 | 2018-03-06 | Theranos Ip Company, Llc | Methods and devices for sample collection and sample separation |
| US10248765B1 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample collection, transport, and handling |
| US10244973B2 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample transport |
| US10371606B2 (en) | 2015-07-21 | 2019-08-06 | Theraos IP Company, LLC | Bodily fluid sample collection and transport |
| US10890513B2 (en) | 2015-09-14 | 2021-01-12 | National University Corporation Shiga University Of Medical Science | Cell-holding substrate holder for preparing observation specimen, kit including same, and observation specimen preparation method |
| US11007527B2 (en) | 2015-09-09 | 2021-05-18 | Labrador Diagnostics Llc | Devices for sample collection and sample separation |
| US20210204918A1 (en) * | 2015-06-08 | 2021-07-08 | Boehringer Ingelheim Vetmedica Gmbh | Method for obtaining a saliva sample and collecting device |
| US11391744B2 (en) | 2015-06-08 | 2022-07-19 | Arquer Diagnostic Limited | Methods and kits |
| US11519916B2 (en) | 2015-06-08 | 2022-12-06 | Arquer Diagnostics Limited | Methods for analysing a urine sample |
| US11857966B1 (en) | 2017-03-15 | 2024-01-02 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
| EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
| US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
| US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
| US20090302190A1 (en) | 2006-10-25 | 2009-12-10 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Chip holder, fluidic system and chip holder system |
| HUE031848T2 (en) | 2008-09-20 | 2017-08-28 | Univ Leland Stanford Junior | Non-invasive diagnosis of fetal aneuploidy by sequencing |
| EP2350652A2 (en) | 2008-10-10 | 2011-08-03 | Cnrs-Dae | Cell sorting device |
| US8551425B2 (en) * | 2009-05-20 | 2013-10-08 | California Institute Of Technology | Method for cancer detection, diagnosis and prognosis |
| DE102011076221B3 (de) * | 2011-05-20 | 2012-07-12 | Siemens Aktiengesellschaft | Automatisierter CTC Nachweis |
| CN102871771B (zh) * | 2012-09-04 | 2015-02-18 | 清华大学 | 利用旋转组合模具制备纺锤状复杂器官前体的方法 |
| US10247647B2 (en) | 2013-08-09 | 2019-04-02 | Hitachi Chemical Company, Ltd. | Cell trapping device, cell trapping system, and production method for cell trapping device |
| FR3012978A1 (fr) | 2013-11-12 | 2015-05-15 | Biocarecell | Filtre biocompatible et procede de fabrication d'un filtre biocompatible. |
| WO2021054899A1 (en) * | 2019-09-18 | 2021-03-25 | Nitto Denko Corporation | Biofluid dispensing and assay apparatuses |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888770A (en) * | 1971-10-21 | 1975-06-10 | Shlomo Avital | Plural-sample filter device |
| US4985631A (en) * | 1988-02-16 | 1991-01-15 | Wannlund Jon C | Luminescence exposure apparatus |
| US5219762A (en) * | 1988-12-27 | 1993-06-15 | Mochida Pharmaceutical Co., Ltd. | Method and device for measuring a target substance in a liquid sample |
| US5283039A (en) * | 1991-09-18 | 1994-02-01 | Minnesota Mining And Manufacturing Company | Multi-well filtration apparatus |
| US5306420A (en) * | 1990-01-26 | 1994-04-26 | Biocom Societe Anonyme | Modular device for collecting, incubating, and filtering multiple samples |
| US5624815A (en) * | 1992-03-20 | 1997-04-29 | Celsis International Plc | Method and apparatus for the analysis of biological material |
| US20020028431A1 (en) * | 1998-08-25 | 2002-03-07 | Julien Jean-Claude Bisconte De Saint | Process, device and reagent for cell separation |
| US6375856B1 (en) * | 1998-12-15 | 2002-04-23 | Fuju Photo Film Co., Ltd. | Method of recovering blood filtration residues |
| US20050049793A1 (en) * | 2001-04-30 | 2005-03-03 | Patrizia Paterlini-Brechot | Prenatal diagnosis method on isolated foetal cell of maternal blood |
| US20060051249A1 (en) * | 2002-04-30 | 2006-03-09 | Gunther Knebel | Device for protein crystallisation |
| US20070065811A1 (en) * | 2003-09-03 | 2007-03-22 | Keizer Gerrit D | Method of detecting multiple analytes |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4510119A (en) * | 1982-05-07 | 1985-04-09 | Centocor, Inc. | Diagnostic test bead transfer apparatus |
| US4493815A (en) * | 1983-07-28 | 1985-01-15 | Bio-Rad Laboratories, Inc. | Supporting and filtering biochemical test plate assembly |
| US4787988A (en) * | 1987-02-20 | 1988-11-29 | Biomedical Research And Development Laboratories, Inc. | Cell harvester |
| FR2638101B1 (fr) * | 1988-10-21 | 1991-09-06 | Biocom Sa | Dispositif de filtration parallele d'une pluralite d'echantillons avec controle automatique des volumes filtres et du colmatage ainsi qu'avec indexation du filtre, et procede de filtration |
| EP1065001B1 (en) * | 1998-03-19 | 2008-09-24 | Precision System Science Co., Ltd. | Apparatus for integrating processing of magnetic particles, and method of controlling the same |
| FR2809142A1 (fr) * | 2000-05-18 | 2001-11-23 | Clauger | Dispositif de fixation a came de serrage amovible |
| NZ528650A (en) * | 2001-03-08 | 2005-09-30 | Exelixis Inc | Multi-well apparatus |
| US7166443B2 (en) * | 2001-10-11 | 2007-01-23 | Aviva Biosciences Corporation | Methods, compositions, and automated systems for separating rare cells from fluid samples |
| WO2003064585A1 (en) * | 2002-01-25 | 2003-08-07 | Irm, Llc | Devices, systems, and methods of manifolding materials |
| US20040182770A1 (en) * | 2002-12-18 | 2004-09-23 | Phillip Clark | Combination laboratory device with multifunctionality |
| US7507376B2 (en) * | 2002-12-19 | 2009-03-24 | 3M Innovative Properties Company | Integrated sample processing devices |
-
2005
- 2005-03-24 FR FR0502945A patent/FR2883488B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-14 CA CA2601451A patent/CA2601451C/fr not_active Expired - Lifetime
- 2006-03-14 HU HUE13159197A patent/HUE032161T2/en unknown
- 2006-03-14 EP EP06726089.3A patent/EP1866091B1/fr not_active Expired - Lifetime
- 2006-03-14 DK DK13159197.6T patent/DK2633912T3/en active
- 2006-03-14 ES ES06726089.3T patent/ES2549856T3/es not_active Expired - Lifetime
- 2006-03-14 US US11/908,545 patent/US20090226957A1/en not_active Abandoned
- 2006-03-14 EP EP13159197.6A patent/EP2633912B1/fr not_active Expired - Lifetime
- 2006-03-14 JP JP2008502434A patent/JP5254000B2/ja not_active Expired - Lifetime
- 2006-03-14 WO PCT/FR2006/000562 patent/WO2006100366A2/fr not_active Ceased
-
2010
- 2010-10-15 FR FR1058439A patent/FR2947738B1/fr not_active Expired - Fee Related
-
2014
- 2014-10-17 US US14/517,288 patent/US9766167B2/en not_active Expired - Lifetime
-
2017
- 2017-09-18 US US15/707,993 patent/US10436686B2/en not_active Expired - Lifetime
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888770A (en) * | 1971-10-21 | 1975-06-10 | Shlomo Avital | Plural-sample filter device |
| US4985631A (en) * | 1988-02-16 | 1991-01-15 | Wannlund Jon C | Luminescence exposure apparatus |
| US5219762A (en) * | 1988-12-27 | 1993-06-15 | Mochida Pharmaceutical Co., Ltd. | Method and device for measuring a target substance in a liquid sample |
| US5306420A (en) * | 1990-01-26 | 1994-04-26 | Biocom Societe Anonyme | Modular device for collecting, incubating, and filtering multiple samples |
| US5283039A (en) * | 1991-09-18 | 1994-02-01 | Minnesota Mining And Manufacturing Company | Multi-well filtration apparatus |
| US5624815A (en) * | 1992-03-20 | 1997-04-29 | Celsis International Plc | Method and apparatus for the analysis of biological material |
| US20020028431A1 (en) * | 1998-08-25 | 2002-03-07 | Julien Jean-Claude Bisconte De Saint | Process, device and reagent for cell separation |
| US6375856B1 (en) * | 1998-12-15 | 2002-04-23 | Fuju Photo Film Co., Ltd. | Method of recovering blood filtration residues |
| US20050049793A1 (en) * | 2001-04-30 | 2005-03-03 | Patrizia Paterlini-Brechot | Prenatal diagnosis method on isolated foetal cell of maternal blood |
| US20060051249A1 (en) * | 2002-04-30 | 2006-03-09 | Gunther Knebel | Device for protein crystallisation |
| US20070065811A1 (en) * | 2003-09-03 | 2007-03-22 | Keizer Gerrit D | Method of detecting multiple analytes |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104670A1 (en) * | 2007-09-21 | 2011-05-05 | Metagenex | Method, device and molecular biology kit for extracting amplified genetic material |
| US8709786B2 (en) | 2009-11-04 | 2014-04-29 | Screencell | Device and process for isolating and cultivating live cells on a filter or extracting their genetic material |
| US20130074613A1 (en) * | 2010-04-15 | 2013-03-28 | Cytogen Co., Ltd. | Microfluidic device and method for isolating target using same |
| US9372134B2 (en) * | 2010-04-15 | 2016-06-21 | Cytogen Co., Ltd. | Microfluidic device and method for isolating target using same |
| WO2013174948A1 (en) | 2012-05-24 | 2013-11-28 | Rarecells | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| US20130316347A1 (en) * | 2012-05-24 | 2013-11-28 | Rarecells Sas | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| EP3745126A1 (en) | 2012-05-24 | 2020-12-02 | Assistance Publique - Hôpitaux de Paris | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| RU2641595C2 (ru) * | 2012-05-24 | 2018-01-18 | Рарсель | Способ проведения мульти-анализов редких клеток, экстрагированных или выделенных из биологических образцов фильтрацией |
| EP3351935A1 (en) | 2012-05-24 | 2018-07-25 | Assistance Publique-Hôpitaux de Paris | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| AU2013265267B2 (en) * | 2012-05-24 | 2018-08-02 | Assistance Publique - Hopitaux De Paris | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| AU2013265267C1 (en) * | 2012-05-24 | 2019-01-31 | Assistance Publique - Hopitaux De Paris | Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| US10248765B1 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample collection, transport, and handling |
| US10244973B2 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample transport |
| US20140323911A1 (en) * | 2013-03-15 | 2014-10-30 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
| US9908113B2 (en) | 2013-03-15 | 2018-03-06 | Theranos Ip Company, Llc | Methods and devices for sample collection and sample separation |
| CN103255055A (zh) * | 2013-04-24 | 2013-08-21 | 宁波美晶医疗技术有限公司 | 一种卡扣型生物芯片 |
| US20210204918A1 (en) * | 2015-06-08 | 2021-07-08 | Boehringer Ingelheim Vetmedica Gmbh | Method for obtaining a saliva sample and collecting device |
| US11391744B2 (en) | 2015-06-08 | 2022-07-19 | Arquer Diagnostic Limited | Methods and kits |
| US11519916B2 (en) | 2015-06-08 | 2022-12-06 | Arquer Diagnostics Limited | Methods for analysing a urine sample |
| US10371606B2 (en) | 2015-07-21 | 2019-08-06 | Theraos IP Company, LLC | Bodily fluid sample collection and transport |
| US11305275B2 (en) | 2015-07-21 | 2022-04-19 | Labrador Diagnostics Llc | Bodily fluid sample collection and transport |
| US11007527B2 (en) | 2015-09-09 | 2021-05-18 | Labrador Diagnostics Llc | Devices for sample collection and sample separation |
| US11247208B2 (en) | 2015-09-09 | 2022-02-15 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
| US10890513B2 (en) | 2015-09-14 | 2021-01-12 | National University Corporation Shiga University Of Medical Science | Cell-holding substrate holder for preparing observation specimen, kit including same, and observation specimen preparation method |
| US11857966B1 (en) | 2017-03-15 | 2024-01-02 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2633912A1 (fr) | 2013-09-04 |
| EP1866091B1 (fr) | 2015-07-29 |
| EP1866091A2 (fr) | 2007-12-19 |
| US20150104791A1 (en) | 2015-04-16 |
| HUE032161T2 (en) | 2017-09-28 |
| US20180003602A1 (en) | 2018-01-04 |
| JP2008537485A (ja) | 2008-09-18 |
| FR2947738B1 (fr) | 2014-06-13 |
| JP5254000B2 (ja) | 2013-07-31 |
| FR2883488A1 (fr) | 2006-09-29 |
| WO2006100366A2 (fr) | 2006-09-28 |
| CA2601451C (fr) | 2013-07-16 |
| CA2601451A1 (fr) | 2006-09-28 |
| DK2633912T3 (en) | 2017-03-13 |
| ES2549856T3 (es) | 2015-11-02 |
| WO2006100366A3 (fr) | 2007-09-20 |
| US10436686B2 (en) | 2019-10-08 |
| US9766167B2 (en) | 2017-09-19 |
| FR2947738A1 (fr) | 2011-01-14 |
| FR2883488B1 (fr) | 2010-12-10 |
| EP2633912B1 (fr) | 2016-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10436686B2 (en) | Process and device for separating biological particles contained in a fluid by means of filtration | |
| DK2954758T3 (en) | plasma Source | |
| US5578459A (en) | Method and apparatus for collecting a cell sample from a liquid specimen | |
| JP3540323B2 (ja) | 体液試験 | |
| US5301685A (en) | Method and apparatus for obtaining a cytology monolayer | |
| EP0787987A2 (en) | Liquid specimen container and attachable testing modules | |
| WO1998020352A2 (en) | Method and apparatus for collecting a cell sample from a liquid specimen | |
| KR20130064048A (ko) | 다수의 세포 현탁액 제조 및 분석용 자동 방법 및 자동화 디바이스 | |
| CA3076601C (en) | Chip for cell classification | |
| US20210372894A1 (en) | Medical apparatus and method for collection and preparation of biological samples | |
| DE102009052671B4 (de) | Vorrichtung und Verfahren zur Behandlung eines Filtrationsmediums | |
| JPH0355090Y2 (https=) | ||
| US6106483A (en) | Apparatus for obtaining a cytology monolayer | |
| HK1189850B (en) | Device for separating by vertical filtration of biological particles contained in a liquid | |
| HK1189850A (en) | Device for separating by vertical filtration of biological particles contained in a liquid | |
| JP2024527886A (ja) | 分析又は診断目的の生体試料を調製するための装置及び方法 | |
| AU733273B2 (en) | Body fluid testing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UNIVERSITE RENE DESCARTES-PARIS V, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PATERLINI-BRECHOT, PATRIZIA;REEL/FRAME:021562/0546 Effective date: 20080808 Owner name: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PATERLINI-BRECHOT, PATRIZIA;REEL/FRAME:021562/0546 Effective date: 20080808 Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHECHE ME Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PATERLINI-BRECHOT, PATRIZIA;REEL/FRAME:021562/0546 Effective date: 20080808 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |